| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Finance > How I Paid Off The Mortgage By Trading |
|
Just Other Articles - How I Paid Off The Mortgage By Trading
Well, its taken me long enough to do it but I decided that as I had made enough money trading options in 2006 I would pay it off. It wasn't a huge mortgage by some According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product standards but its just one less thing to think about. Very interestingly, another trader friend and my bank manager said that I should reinvest it and make more ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in money with it, but this way I save myself a heap of interest at 5% and get some peace of mind. Additionally I want to use the rest of my trading profits I make nex lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. t year to pay for my place in Barbados !! If people out there are reading this and thinking , hey trading must be easy if this guy can do it. Well yeah, it is and here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe it isn't. I have had quite a few losses along the way, but overall I have made more money than I have lost, which, going by some of my friends and colleagues, is d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro etter than most In a bid to become a successful trader I have tried pretty much every financial instrument in my life. Futures,Warrants,Shares,Bonds,ETFs etc. If ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc these instruments could play music I would definitely be a one man band ! There are two main reasons why options have become the tool of choice for me. T easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ime. Time can play an important role when making a strategic decision about a share. With options,you can literally sell time and make money from it. Fo nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically r example, if you think a share will go up, sure, go ahead and buy the share. But what happens if your research leads you to believe that the share will go nowhere and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ . How can you profit from that ? This is where options come in Imagine the following scenario. Company X has had an OK year. It has told the market that the resul ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi s will be OK this year and the share price fell a little and is trading at $20. It expects to do better next year though. It has a good balance sheet with very lit ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a tle debt and no real skeletons in its cupboard and pays a decent slightly above average dividend. There is no real reason to buy the share but no reason to sell i dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod t either and the results are due out in 3 months time. What can you do ? If the company has tradable options, you can sell (write) a 20 put option for say $2 that cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin will expire in 3 months time. This means the broker will buy an option from you and in return give you some money. Each option is worth 100 shares so selling 1 co tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ntract would give you $200. The real bonus is that if the share price remains at $20 or goes up, you get to keep all the money. If the share price falls, then you t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ust give back some or all of the money depending on how far it falls. Your breakeven point is $18 What I like to do is find these really good shares, wait until t ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust hey or the market has a bad day and then sell the option. If you sell the option when the share price goes down, you get more money for it. Of course, I am making y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products it sound simple for demonstration purposes but there is merit in investigating this furrther. The key to being successful with options is to understand (i.e. have . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de a strong view) on the share, index or commodity on which you are betting. Oh yes, I mentioned two reasons didn’t I. Well, if you are interested you will just hav elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Best Business Card I Ever Saw You Won't Believe the Power of This Word! Targeted Email Marketing – First 5 Steps of Targeted Email Marketing
|